Neuromagen PharmaNeuromagen Pharma
Neuromagen Pharma

Neuromagen Pharma

Early-stage pharmaceutical company developing novel small molecules to activate telomerase for aging-related diseases.

2021Active3

About

Neuromagen Pharma pioneers telomerase-activated therapies for neurodegenerative and age-related diseases. Their compounds, demonstrated in murine models, show therapeutic results in conditions like ALS and Alzheimer's by preserving neuronal integrity and reducing inflammation. The company's science also supports potential applications in cardiovascular health, metabolic disorders, reproductive rejuvenation, and hair regeneration.

Technology stack

detected 2026-06-16
Est. monthly stack spend~$70/mo
CDN
Cloudflare
EmailGoogle Workspace
Stack
WordPress
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Neuromagen Pharma do?

Neuromagen Pharma pioneers telomerase-activated therapies for neurodegenerative and age-related diseases. Their compounds, demonstrated in murine models, show therapeutic results in conditions like ALS and Alzheimer's by preserving neuronal integrity and reducing inflammation. The company's science also supports potential applications in cardiovascular health, metabolic disorders, reproductive rejuvenation, and hair regeneration.

Where is Neuromagen Pharma headquartered?

Neuromagen Pharma is headquartered in San Diego, United States.

When was Neuromagen Pharma founded?

Neuromagen Pharma was founded in 2021.

What industry does Neuromagen Pharma operate in?

Neuromagen Pharma operates in Food, Dairy, Protein, Biotech, Drug Discovery, Longevity.

How many employees does Neuromagen Pharma have?

Neuromagen Pharma has approximately 3 people on record.